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Background: Influenza A viruses (IAVs) are important pathogens that affect the health of humans and many additional
animal species. IAVs are enveloped, negative single-stranded RNA viruses whose genome encodes at least ten proteins.
The IAV nucleoprotein (NP) is a structural protein that associates with the viral RNA and is essential for virus replication.
Understanding how IAVs interact with host proteins is essential for elucidating all of the required processes for viral
replication, restrictions in species host range, and potential targets for antiviral therapies.
Methods: In this study, the NP from a swine IAV was cloned into a yeast two-hybrid “bait” vector for expression of a
yeast Gal4 binding domain (BD)-NP fusion protein. This “bait” was used to screen a Y2H human HeLa cell “prey” library
which consisted of human proteins fused to the Gal4 protein’s activation domain (AD). The interaction of “bait” and
“prey” proteins resulted in activation of reporter genes.
Results: Seventeen positive bait-prey interactions were isolated in yeast. All of the “prey” isolated also interact in yeast
with a NP “bait” cloned from a human IAV strain. Isolation and sequence analysis of the cDNAs encoding the human
prey proteins revealed ten different human proteins. These host proteins are involved in various host cell processes
and structures, including purine biosynthesis (PAICS), metabolism (ACOT13), proteasome (PA28B), DNA-binding
(MSANTD3), cytoskeleton (CKAP5), potassium channel formation (KCTD9), zinc transporter function (SLC30A9), Na+/K+
ATPase function (ATP1B1), and RNA splicing (TRA2B).
Conclusions: Ten human proteins were identified as interacting with IAV NP in a Y2H screen. Some of these human
proteins were reported in previous screens aimed at elucidating host proteins relevant to specific viral life cycle
processes such as replication. This study extends previous findings by suggesting a mechanism by which these host
proteins associate with the IAV, i.e., physical interaction with NP. Furthermore, this study revealed novel host protein-NP
interactions in yeast.
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Influenza A viruses (IAVs) are important pathogens that
affect the health of humans and many additional animal
species. In humans, seasonal IAV infection presents as a
non-fatal, uncomplicated, acute infection characterized
by the presence of upper respiratory symptoms as well
as fever, headache, soreness and fatigue lasting 2–5 days
[1]. However, deaths from seasonal IAV infections often* Correspondence: heidi.sleister@drake.edu
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unless otherwise stated.arise when the normal flu symptoms are exacerbated by
compromised immunity or age [1]. In addition to seasonal
influenza A viruses, pandemic strains periodically appear
causing increased mortality rates. For example, the 1918
Spanish flu resulted in approximately 50 million human
deaths [2]. The most recent pandemic resulted from the
emergence of the swine-origin H1N1 virus [3,4]. Due to
influenza A’s potential for mortality, high mutation rates
(resulting in genetic drift) and pandemic potential (result-
ing from genetic reassortment), it is critical to learn more
about the virus, especially as it pertains to virulence,ral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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development of therapeutics.
Influenza A viruses exhibit a broad host range beyond
humans [5]. Waterfowl serve as the central reservoir spe-
cies. In addition to humans, various IAV subtypes circulate
in pigs, poultry, horses, dogs as well as other species. Sub-
types (H1N1 and H3N2) that circulate in the human
population also circulate in the swine populations [6]. In
addition to the concern for IAV in terms of swine health
[7], IAV infection in swine is also important due to the
potential for zoonotic infections as well as the potential
for serving as a mixing vessel for the generation of human
pandemic viruses [5]. The majority of inter-species trans-
mission research has focused on amino acids in the
hemagglutinin affecting viral attachment and entry [8]. Al-
though known to be important, other than amino acids
associated with temperature sensitivity (e.g., PB2 627 [9]
or 701 [10]), the effects of differences in amino acid
residues in proteins of the replication complex on species
specificity is less well understood. Previous evidence sug-
gests that there may be a role in some of these replication
complex proteins in allowing for zoonotic infections [11].
The genome of the enveloped influenza A virion consists
of eight segments of negative-sense single-stranded RNA
that encode at least ten viral genes: Hemagglutinin (HA),
Neuraminidase (NA), Matrix 2 protein (M2), Matrix 1 pro-
tein (M1), Non-structural Protein 1 (NS1), Non-structural
Protein 2 (NS2), Nucleoprotein (NP), Polymerase Basic 1
(PB-1), Polymerase Basic 2 (PB-2), and Polymerase Acidic
(PA) [1]. The viral envelope contains HA, NA, and M2
proteins, and M1 proteins form a layer inside the envelope.
The IAV RNA genome located inside the virion is coated
with NP and is bound by the replication complex consist-
ing of PB1, PB2, and PA. The NP, the focus of this study,
encoded by the fifth IAV RNA segment, binds with high af-
finity to viral RNA [12]. NP plays a role in viral RNA repli-
cation and transcription [12]. More recent data suggests
that NP binds the polymerase as well as the newly repli-
cated RNA and may act as a processivity factor that is
necessary for replication of the viral RNA to be completed
[13]. Phylogenic analysis of IAV NP shows distinct lineages
of NP based on the host species [14,15]. Within the NP,
there are amino acid signatures found within different host
species [16,17]. These host-specific amino acid residues
may result in differences in affinities for the various host
proteins with which they interact (e.g., importin α1 [18],
F- actin [19], nuclear factor 90 [20], cyclophilin E [21],
exportin 1 [22], HMGB1 [23], HMGB2 [23], MxA/Mx1
[24,25], HSP40 [26], karyopherin alpha [27,28], clusterin
[29], Raf-2p48/BAT1/UAP56 [30], Aly/REF [31], Tat-SF1
[32], TRIM22 [33], and alpha actinin 4 [34]) or they may
result in differences in how the NP interacts with other
viral proteins that have also made host-specific adaptations
[11]. Given the suggestion that NP plays a role indetermining host range [5,35-37], it is important to identify
all host proteins that interact with NP.
Replication of the IAV is dependent on the host cell ma-
chinery and interactions between host proteins and viral
proteins. Therefore any inquiry attempting to investigate
the life cycle of IAV must incorporate host-pathogen pro-
tein interactions in order to truly provide a mechanistic
understanding of the process. Previous screens have
identified important protein-protein interactions between
IAV and host proteins, but often results are not consistent
between screens. Therefore, corroborating evidence with
additional screens is crucial to accumulating the best
understanding of critical pathogen-host interactions in
viral replication. As examples, several genome-wide
screens have been performed using RNAi to systematically
knockdown host genes and evaluate the effect on various
stages of the IAV life cycle [38-41]. An integrated ap-
proach carried out by Shapira and colleagues involved
transcription profiling and yeast two hybrid screens using
specific viral proteins as baits [28]. Proteomics approaches
have revealed host proteins found within viral particles
[42,43]. The Random Homozygous Gene Perturbation
strategy was used to identify host factors that prevent
influenza-mediated killing of host cells [44].
In order to better understand the role of NP-host pro-
tein interactions in IAV replication, a Gal4-based yeast
two-hybrid (Y2H) assay was used in this study. The Y2H
system allows for the identification of unique human
binding partners with NP. A “bait” plasmid encoding the
binding domain (BD) of the Gal4 transcriptional activator
fused to NP and a “prey” plasmid encoding Gal4’s activa-
tion domain (AD) fused to a protein encoded by a human
cDNA are introduced into a yeast strain containing Gal4-
responsive reporter genes. Interaction of the bait and prey
brings together Gal4’s BD and AD, resulting in transcrip-
tional activation of reporter genes [45]. The Y2H approach
has successfully identified cellular factors (e.g., Raf-2p48/
BAT1/UAP56, Hsp40, KPNA1, KNPA3, KPNA6, C16or
f45, GMCL1, MAGED1, MLH1, USHBP1, ZBTB25, CLU,
Aly/REF, and ACTN4) that interact with the IAV NP
[26-31,34], (Table 1). In this study, the nucleoprotein from
a classical swine H1N1 IAV (Sw/NC/44173/00) was used
as the “bait” in a Y2H screen against a “prey” HeLa cDNA
library. To investigate if the origin of NP affects the ability
of the interactions to take place, the nucleoprotein from a
contemporary human H3N2 IAV (A/Ca/07/04) was also
used as the “bait” in a Y2H screen against the same prey
HeLa cDNA library. By determination of the putative
interaction partners between NP and human proteins, the
possible functions of the newfound protein-protein inter-
actions or verification and perhaps elucidation of previ-
ously identified host factors may be further investigated.
Reported herein are ten potential human host cell
proteins that interact with IAV NP in a Y2H screen. The
Table 1 Summary of identified bait-prey interactions and previous reports of host protein association with
influenza A virus
Gene Protein description Complete ORF Number of prey clones Prey clones Previous reports with IAV
PAICS Phosphoribosylaminoimidazole
carboxylase
Yes 3 R3, R9, R15 Karlas et al. [40], Kumar and
Nanduri [47], Kroeker et al. [48]
MSANTD3 Myb/SANT-like DNA-binding domain
containing 3
No 3 R10, R13, R27 N/A
FLJ30306 PREDICTED: Homo sapiens
uncharacterized LOC101059922, mRNA
Yes 2 R23, R33 N/A
PA28B Proteasome activator subunit 2 Yes 2 R6, R19 N/A
KCTD9 Potassium channel tetramerisation
domain containing 9
No 2 R34, R36 N/A
ACOT13 Acyl-CoA thioesterase 13 Yes 1 R11 N/A
TRA2B Transformer 2 beta homolog
(Drosophila)
Yes 1 R12 Zhu et al. [56]
SLC30A9 Solute carrier family 30 (zinc
transporter), member 9
No 1 R28 Kumar and Nanduri [47],
Sui et al. [44]
ATP1B1 ATPase, Na+/K+ transporting, beta 1
polypeptide
No 1 R7 Mi et al. [51], Liu et al. [50]
CKAP5 Cytoskeleton associated protein 5 No 1 R29 N/A
Host proteins identified as interacting with IAV nucleoprotein in previously published yeast two-hybrid screens
BAT1/UAP56 RNA-dependent ATPase N/A N/A N/A Momose et al. [30]
HSP40 Heat shock protein 40 N/A N/A N/A Sharma et al. [26]
NPI-1/ SRP1/
KPNA1
Karyopherin α1 N/A N/A N/A O’Neill and Palese [27],
Shapira et al. [28]
KPNA3 Karyopherin α3 N/A N/A N/A Shapira et al. [28]
KPNA6 Karyopherin α6 N/A N/A N/A Shapira et al. [28]
C16orf45 - N/A N/A N/A Shapira et al. [28]
GMCL1 Germ cell-less, spermatogenesis
associated 1
N/A N/A N/A Shapira et al. [28]
MAGED1 Melanoma antigen family D.1 N/A N/A N/A Shapira et al. [28]
MLH1 MutL homolog 1 N/A N/A N/A Shapira et al. [28]
USHBP1 Usher syndrome 1C binding protein 1 N/A N/A N/A Shapira et al. [28]
ZBTB25 Zinc finger and BTB domain
containing 25
N/A N/A N/A Shapira et al. [28]
CLU Clusterin N/A N/A N/A Tripathi et al. [29]
ALY/REF RNA export adaptor protein N/A N/A N/A Balasubramaniam et al. [31]
ACTN4 Alpha-actinin 4 N/A N/A N/A Sharma et al. [34]
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were characterized by a plating assay and beta-galacto
sidase assay.
Results
Constructing an NP bait and screening a human cDNA
prey library
The nucleoprotein open reading frame from the classical
swine IAV H1N1 strain A/Sw/NC/44173/00 and contem-
porary human IAV H3N2 strain A/Ca/07/04 encode pro-
teins with 89.1% identity and 94.8% similarity (Figure 1).
Of the 49 amino acids that differ between the swine andhuman NPs, 29 are conservative differences. However, it is
worth noting that several of these amino acid differences
are signatures that differ between avian, swine and human
isolates [16,17]. The two NP ORFs were amplified by
PCR, and the resulting PCR products were separately
inserted by recombination cloning into Y2H bait vector
pGBKT7 as a C-terminal fusion with Gal4p’s DNA bind-
ing domain. Correct constructs were confirmed by DNA
sequence analysis. Gal4(BD)-NP fusion proteins isolated
from yeast cells were detected as 77 KDa bands on a
Western blot probed with an anti-Myc antibody (data not
shown). When introduced alone into yeast Y2HGold cells,
Figure 1 Sequence alignment of nucleoproteins from swine and human influenza A virus strains. The swine and human NPs are 89.1%
identical (yellow highlighting) and 94.8% similar (yellow and green highlighting). Nonconservative amino acids differences are represented in
white. Amino acids with * represent signature amino acids associated with avian influenza A NP, and # and † represent signature amino acids
associated with avian influenza A NP based on Chen et al. [16] and Pan et al. [17]. † Denotes the only deviation of A/Sw/NC 44173/00 from the
consensus swine residues based on Pan et al. [17].
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to yeast and did not autoactivate the Y2H reporter genes,
indicating they were suitable for use in a Y2H screen (data
not shown).
Using a Y2H assay with Gal4 (BD)-swine NP as a bait and
a human HeLa cDNA prey library, approximately 2 × 106
clones were screened resulting in 17 positive bait-prey
interacting yeast strains. Sequence and bioinformatics
analysis of the prey plasmids indicated that these 17
prey plasmids, listed by their initial positive interaction
identification number (R3, R6, etc.), represent ten different
human cDNAs (Table 1). An independent screen using
Gal4 (BD)-human NP as a bait and a human HeLa cDNA
prey library yielded a subset of these same host protein
targets. Some of the identified clones contain partial
cDNAs. Three independent prey plasmids isolated con-
tained human cDNAs phosphoribosylaminoimidazole
carboxylase, phosphoribosylaminoimidazole succinocar-
boxamide synthetase (PAICS) and another three con-
tained Myb/SANT-like DNA-binding domain containing
3 (MSANTD3). Two independent prey plasmids were iso-
lated for each of three human cDNAs: proteasome activa-
tor subunit 2 (PA28B), potassium channel tetramerisation
domain (KCTD9), and an uncharacterized protein
(FLJ30306). Each of the remaining five prey plasmids con-
tained different human cDNAs.Evaluation of the strength of bait-prey interactions
The strength of interaction between each NP bait (swine
or human) and human prey in yeast was measured using a
qualitative growth assay and a quantitative β-galactosidase
activity assay. First, yeast growth on selective media after
cotransformation with swine or human NP and one of the
identified prey was tested at both 30°C and 37°C as a
qualitative metric of the protein-protein interaction’s
strength (Figure 2, Table 2). All strains, including the posi-
tive and negative controls, grew on SD-Leu-Trp which se-
lects for the presence of both bait and prey plasmids.
Most strains showed decreased growth at 37°C relative to
the more permissive temperature 30°C. Strains examined
at 37°C which contained either swine or human NP bait
grew best in the presence of prey CKAP5, MSANTD3, or
TRA2B. In contrast, at 37°C strains containing swine NP
grew poorly with prey ACOT13, whereas strains contain-
ing human NP grew poorly with prey PA28B.
The strength of the interactions between IAV NP and
host proteins identified by the library screen was also inves-
tigated by measuring the β-gal activity in liquid yeast cul-
tures (Figure 3, Table 2). As observed with the qualitative
growth assay, for all ten prey proteins, interactions were
observed with both the swine and human NP. Of the ten
interactions investigated, yeast strains containing swine or
human NP and human prey SLC30A9 and CKAP3 showed
Figure 2 Maintenance of protein-protein interactions at 30°C and 37°C. Yeast cells containing both a bait plasmid and prey plasmid were
spotted in duplicate onto agar plates and incubated at 30°C or 37°C. SD-Leu-Trp media serves as a growth control, and SD-His is protein interaction
reporter media. Growth on SD-His is represented as normal growth (++), reduced growth (+), and no growth (−) (see Table 2). NC and PC represent
negative and positive controls, respectively. Additional yeast strain negative controls include h- (human NP bait and empty prey vector) and s-
(swine NP bait and empty prey vector).
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prey proteins examined. This is consistent with the growth
of yeast strains containing human NP and SLC30A9 and
CKAP3 on selective media at 37°C ( Figure 2, Table 2). Even
strains with the lowest levels of β-gal activity observedTable 2 Summary of affinity of bait-prey interactions
Gene Protein description Prey
clone
PAICS Phosphoribosylaminoimidazole carboxylase R15
MSANTD3 Myb/SANT-like DNA-binding domain containing 3 R10
FLJ30306 PREDICTED: Homo sapiens uncharacterized
LOC101059922, mRNA
R23
PA28B Proteasome (prosome, macropain) activator subunit 2 R6
KCTD9 Potassium channel tetramerisation domain
containing 9
R34
ACOT13 Acyl-CoA thioesterase 13 R11
TRA2B Transformer 2 beta homolog (Drosophila) R12
SLC30A9 Solute carrier family 30 (zinc transporter), member 9 R28
ATP1B1 ATPase, Na+/K+ transporting, beta 1 polypeptide R7
CKAP5 Cytoskeleton associated protein 5 R29
* Results from growth on SD-His protein interaction assay media are presented as:
** Mean β-galalactosidase activity from at least eight replicates reported in Miller u(TRA2B and ATP1B1) have double the β-gal activity of the
negative control. While the data suggest there may be dif-
ferences in the strength of bait-prey interactions based on
NP host origin, these differences should be interpreted
carefully given the nature of the assay.Growth on SD-His agar plates* β-Gal activity**
Human
(30°C)
Human
(37°C)
Swine
(30°C)
Swine
(37°C)
Human
NP
Swine
NP
(++) (+) (++) (++) 2.2 30.4
(++) (++) (++) (++) 13.9 18.2
(+) (+) (++) (++) 1.9 5.4
(++) (−) (++) (+) 6.7 33.3
(+) (+) (++) (++) 5.0 16.4
(++) (+) (++) (−) 6.9 15.5
(++) (++) (++) (++) 1.9 0.85
(++) (+) (++) (+) 82.9 119.9
(++) (+) (++) (++) 3.4 4.3
(++) (++) (++) (++) 70.1 90.3
(++) normal growth, (+) reduced growth, and (-) no growth (Figure 2).
nits (Figure 3).
R
2 8
(S
L C
3 0
A
9 )
R
2 9
(C
K
A
P
5 )
R
6
(P
A
2 8
B
)
R
1 5
(P
A
IC
S
)
R
1 0
(M
S
A
N
TD
3 )
R
3 4
(K
C
T D
9 )
R
1 1
(A
C
O
T 1
3 )
R
2 3
(F
L J
3 0
3 0
6 )
R
7
(A
T P
1B
1 )
R
1 2
(T
R
A
2B
)
N
e g
a t
iv
e
C
o n
tr
o l
0
2 0
4 0
6 0
8 0
1 0 0
1 2 0
1 4 0
M
il
le
r
U
n
it
s
H um an
Sw ine
Figure 3 β-galactosidase activity in liquid culture. Β-gal activity is a quantitative measure of the strength of interaction between bait swine or
human NP and prey human host proteins identified in the Y2H screen. The β-gal activity for each interacting bait-prey pair is expressed in Miller
units and represents the mean and standard error of the mean of at least eight independent samples.
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This Y2H screen identified multiple candidate host pro-
teins that were previously identified in genome-wide
screens as playing a role in the IAV infection cycle
(PAICS, ATP1B1, SLC30A9, and TRA2B), while also iden-
tifying new potential interactors with IAV nucleoprotein
(ACOT13, CKAP5, KCTD9, PA28B, MSANDTD3, and
FLJ30306). These results complement previous reports by
suggesting the mechanism for involvement of the host
proteins with the IAV (i.e. interaction with the NP). The
yeast screen is internally validated by the observation that
half of the prey proteins identified were independently
isolated multiple times during the screen. All host prey
proteins identified interact in yeast with IAV NP from
both human and swine isolates. Although there can be
variability in gene expression among yeast colonies con-
taining the same combination of bait/prey, both a qualita-
tive growth assay and a quantitative β-gal assay yielded
similar results in terms of the strength of interaction be-
tween IAV NP bait and human prey proteins. Notably,
CKAP5 displayed good growth at the more stringent 37°C
in the qualitative assay and also had high β-gal activity.
The putative interacting host proteins represent a varietyof cellular processes, consistent with the diversity of pro-
cesses required during the IAV infection cycle.
Phosphoribosylaminoimidazole carboxylase, phosphoribo-
sylaminoimidazole succinocarboxamide synthetase (PAICS)
is an enzyme necessary to catalyze the sixth and seventh
steps of the de novo purine biosynthesis pathway [46].
PAICS has been identified by two separate RNAi screens as
being crucial to IAV replication [40,47]. Furthermore,
proteins involved in purine biosynthesis, including PAICS,
were found to be significantly up-regulated during an IAV
infection [48]. The data presented herein suggest that the
requirement for PAICS during IAV infection may be
through the interaction with NP.
The sodium/potassium-transporting ATPase subunit
beta-1 (ATP1B1) represents another host protein that inter-
acts in yeast with NP and that has been previously shown
to be important for influenza virus replication in host cells.
It belongs to the family of Na+/K + −ATPase beta chain
proteins. Na+/K +−ATPase is necessary for the creation
and maintenance of electrochemical gradients of sodium
and potassium ions on either side of the plasma membrane
[49]. This gradient is used by cells to permit functional ner-
vous and muscular excitability, osmoregulation, and active
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functions to regulate the quantity of sodium pumps trans-
ported to the plasma membrane [49]. Using a quantitative
proteomics approach, ATP1B1 was one of 43 proteins
found to be significantly up-regulated in IAV-infected pri-
mary human alveolar macrophages [50]. In a Y2H study,
Mi and colleagues [51] isolated ATP1B1 as a protein that
binds the cytoplasmic domain of IAV M2 and subsequently
showed that knockdown of ATP1B1 in MDCK cells sup-
pressed IAV replication [51]. These studies suggest that
ATP1B1 may be interacting with multiple IAV proteins.
The solute carrier family 30 (zinc transporter), member
9 (SLC30A9) is involved in nucleotide-excision repair of
human DNA [52] and has an efflux motif characteristic of
proteins in the SLC30 zinc efflux transporter family [53].
SLC30A9 protein found in the cytoplasm can bind nuclear
receptors and/or nuclear receptor coactivators and trans-
locate to the nucleus where it regulates gene transcription
[54]. SLC30A9 was identified as a possible host target that
confers upon the host cell resistance to IAV infection [44].
How SLC30A9 might interact with NP and be necessary
for IAV replication is unclear.
Another protein identified by this screen is TRA2B, a
tissue-specific splicing factor [55]. TRA2B protein binds
to AGAA and CAA RNA sequences affecting the inclu-
sion of introns in the processed transcript [55]. With
respect to influenza, expression of TRA2B protein was re-
ported to be down-regulated in porcine alveolar macro-
phage cells infected by two swine IAVs [56]. Because
influenza genes M2 and NS2 are spliced, it is possible that
TRA2B is important for the splicing of these genes. How-
ever, how NP might be involved in TRA2B’s function in
IAV replication is unknown.
Another binding partner identified is Acyl CoA thioes-
terase 13 (ACOT13), a eukaryotic protein also known as
thioesterase superfamily member 2 (Them2) [57,58].
ACOT13 catalyzes fatty acyl-CoA hydrolysis that exists
primarily in association with mitochondria [57]. ACOT13/
Them2 was identified in a Y2H screen focused on phos-
phatidylcholine transfer protein, suggestive of a role in fatty
acid metabolism [57]. Although ACOT13 has not previ-
ously been reported to play a role in the IAV life cycle,
another member of the ACOT family (ACOT9) which has
two hot dog fold domains (ACOT13 has one) [59] has
been shown to physically interact with the IAV PA protein
[28]. How ACOT13 may be interacting with NP during
IAV replication is unclear.
Cytoskeletal associated protein 5 (CKAP5, also known
as TOG) binds microtubules and is important for the
process of centrosomal microtubule assembly especially
during mitosis [60]. The microtubule network of the cell
plays a role in movement of materials throughout the cell,
including during infection [61]. TOG2 binds to a ribonu-
cleoprotein and plays a role in RNA trafficking [62]. Whilea specific role for CKAP5 in the IAV life cycle is unknown,
a genome-wide siRNA screen revealed CKAP5 as one of
96 human genes that supports replication of another RNA
virus- the hepatitis C virus [63]. It’s possible that CKAP5
functions during the IAV infection cycle to organize
microtubules for trafficking of viral components.
Another interactor identified in this screen, KCTD9,
has been previously shown to interact with a subunit of
the Mediator complex, acting as a scaffold between
regulatory proteins and the RNA polymerase II [64]. In
addition, KCTD9 homolog FIP2 acts as a cytoskeletal re-
arrangement protein suspected to be involved in nuclear
export in some plants through the organization of actin
cables [64]. Perhaps KCTD9 aids in translocating NP to
the nucleus for replication and transcription of the viral
RNA. It has been shown that the translocation of NF-E2
related factor 2 (Nrf2) is mediated by cytoskeletal
rearrangement in the oxidative stress response [65], and
the level of Nrf2 expression is associated with IAV entry
and replication in nasal epithelial cells [66].
Also identified by this screen was PA28B, a protein
associated with the proteasome complex. In the typical
proteasome, there is a 19S regulator, which is replaced
by the 11S regulator in the modified immunoproteasome
[67]. PA28B is part of the proteasome complex and acts
as a subunit in the 11S alternate regulator. It is referred
to as the beta subunit and is comprised of three beta
and three alpha subunits arranged in a heterohexameric
ring [68]. The proteasome, as a whole, is used for the
cleaving of peptides and the 11S regulator, in particular,
induces the degradation of short peptides, but not entire
proteins [68]. Induction of 11S regulator expression is the
responsibility of interferon gamma. PA28B is involved in
cleavage of the peptides which bind to the major
histocompatibility complex (MHC). It is possible that NP
interacts with PA28B to prevent MHC I presentation of
IAV antigens.
Myb/SANT-like DNA-binding domain containing 3
(MSANTD3) is a member of the MSANTD3 family which
contains DNA binding domains for Myb proteins and the
SANT domain family. Myb proteins are proto-oncogenes
which are necessary for hematopoiesis and possibly in-
volved in tumorigenesis [69]. The SANT domain permits
the interaction of chromatin remodeling proteins with his-
tones and is found in chromatin-remodeling complexes as
well as nuclear receptor co-repressors [70]. NP interac-
tions with MSANTD3 could have an effect on gene
transcription of the host through chromatin modification,
presumably to inhibit antiviral genes or up-regulate genes
beneficial to viral replication.
The screen also identified FLJ30306 as a potential inter-
actor with NP. FLJ30306 maintains a sequence similarity
to retroviral elements, resulting in its classification as en-
dogenous retrovirus group K3, member 1 [Homo sapiens]
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sequence analysis of the mRNA, not by direct protein
sequencing. It is unclear whether the protein carries out a
normal cellular effect, such as endogenous retrovirus 1’s
(ERV-1) use in placental syncytia formation or if it is a
result of mis-regulation due to influenza infection [71]. In
Hodgkin’s lymphoma it has been shown that many
endogenous retroviruses are reactivated and produce
virus-like particles [71]. It may be that instead of directly
utilizing FLJ30306 influenza may simply be up-regulating
its expression due to its pathogenesis. Alternatively,
FLJ30306 may contain useful enzymatic activity for influ-
enza replication through an unknown mechanism. A
characterization of normal FLJ30306 function would allow
for appropriately testing either hypothesis.
All human host proteins identified in this Y2H screen
interact in yeast with NP from both swine and human IAV
strains. While the data suggest there may be differences in
the strength of bait-prey interactions in yeast based on NP
host origin, these differences should be interpreted care-
fully given the nature of the assay. Given the suggestion
that NP affects species specificity, additional screens using
NP from other IAV strains as the bait and/or cDNA librar-
ies from other susceptible species may shed light on amino
acids within the NP and specific host factors that are
responsible for host restrictions. As is the case with other
published screens (e.g., [72]), it will be important to verify
the putative interactions described here in infected cells by
co-immunoprecipitation, co-localization, or RNA interfer-
ence (e.g., [34]) and to investigate the role of the identified
host proteins in the IAV life cycle.
Conclusions
A Y2H screen using a classical swine influenza A virus nu-
cleoprotein as a bait resulted in isolation of ten different
putative interacting human host proteins involved in a var-
iety of cellular processes and structures: purine biosynthesis
(PAICS), metabolism (ACOT13), proteasome (PA28B),
DNA-binding (MSANTD3), cytoskeleton (CKAP5), potas-
sium channel formation (KCTD9), zinc transporter func-
tion (SLC30A9), Na+/K+ ATPase function (ATP1B1), and
RNA splicing (TRA2B). All of the identified human host
proteins interacted in yeast with NP from both human and
swine origin. Proteins PAICS, ATP1B1, TRA2B, and
SLC30A9 have been previously identified in studies related
to host response to the IAV. Host proteins SLC30A9 and
CKAP5 displayed the strongest interactions with IAV NP in
yeast in a quantitative β-gal assay.
Methods
Strains, plasmids, media, microbial growth conditions,
and reagents
Unless indicated otherwise, yeast strains (Table 3) were
grown in liquid culture at 30°C at 180 rpm and on agarplates at 30°C. Bacterial strains were grown in liquid
culture at 37°C at 200 rpm and on agar plates at 37°C.
Selectable markers for the bait (pGBKT7) and prey
(pGADT7) plasmids in the yeast Saccharomyces cerevi-
siae and bacterium E. coli are listed in Table 3. All media
and Y2H reagents were purchased from Clontech
(Mountain View, CA).
Cloning Influenza A virus nucleoprotein into vector pGBKT7
The open reading frame (ORF) of the nucleoprotein gene
from swine IAV H1N1 strain A/Sw/NC/44173/00 was
amplified from the plasmid pScript A/Sw/NC/44173/00
NP (a gift from Christopher Olsen) by PCR using forward
primer NP3F 5’-CATGGAGGCCGAATTCatggcgtctcaagg-
caccaaacga-3’ and reverse primer NP2R 5’-GCAGGTC-
GACGGATCCattgtcatactcctctgcattgtctccgaaga-3’. The NP
ORF from the human IAV H3N2 strain A/Ca/07/04 was
amplified from plasmid pScript A/Ca/07/04 NP (a gift
from Christopher Olsen) by PCR using forward primer
NP2F 5’-CATGGAGGCCGAATTC atggcgtcccaaggcacca
aacg-3’ and reverse primer NP3R 5’-GCAGGTCGACG
GATCC attgtcgtactcttctgcattgtctccgaaga-3’. For all primers
the uppercase letters represent sequences homologous to
the BamHI-EcoRI-linearized vector pGBKT7, and lower
case letters represent sequences specific for the NP ORF.
Reactions included 200 ng plasmid template DNA, 1X
Advantage HD Buffer (Clontech, Mountain View, CA),
0.2 mM dNTPs, 0.25 μM forward and reverse primers, and
0.625 Units Advantage HD Polymerase (Clontech, Moun-
tain View, CA). Thermocycler conditions were as follows:
95°C for 3 minutes; 30 cycles of [95°C for 15 seconds, 55°C
for 5 seconds, 72°C for 100 seconds], 72°C for 10 minutes.
InFusion cloning (Clontech, Mountain View, CA) was
used to insert the NP ORFs into BamHI-EcoRI-linearized
pGBKT7 3’ and in-frame with DNA encoding Gal4’s DNA
binding domain (BD). Conditions were as follows: 60 ng
gel-purified BamHI-EcoRI-linearized pGBKT7, 50 ng gel-
purified NP PCR product, and 1X InFusion HD Enzyme
Premix in a 5 μl reaction were incubated at 50°C for
15 min. An aliquot of the cloning reaction was trans-
formed into Stellar competent cells per the manufacturer’s
directions (Clontech, Mountain View, CA). All plasmid
sequences were verified by DNA sequencing.
Yeast two-hybrid screen
The Yeast Two-Hybrid MatchMaker Gold system
(Clontech, Mountain View, CA) was used to isolate prey
plasmids that interact with bait pGBKT7-NP. A 50 ml
SD-TRP liquid media culture inoculated with Y2HGold
cells containing the bait plasmid pGBKT7-NP was
grown in a 200 rpm shaker at 30 degrees to an OD600
of 0.8 (approximately 18 hours). Bait cells were pelleted
by centrifugation, resuspended in 4 ml SD-TRP, and
mixed with 45 ml YPDA in a 2 L flask with 2 × 107
Table 3 Strains and plasmids
Yeast strain Genotype Reporter genes
Y2HGold MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ,
LYS2::GAL1UAS–Gal1TATA–His3, GAL2UAS–Gal2TATA–Ade2
URA3::MEL1UAS–Mel1TATA, AUR1-C MEL1
ADE2, HIS3, MEL1, AUR1-C
Y187 ade2-101, trp1-901, leu2-3, 112, gal4Δ, gal80Δ, met–,
URA3::GAL1UAS–Gal1TATA–LacZ, MEL1
MEL1, LacZ
Plasmid Selectable markers (yeast, bacteria) Additional information
Plasmid pGBKT7 (bait vector) TRP1, Kan GAL4(1–147)DNA-BD, TRP1, kanr, c-Myc epitope tag
Plasmid pGADT7 (prey vector) LEU2, Amp GAL4(768–881)AD, LEU2, ampr, HA epitope tag
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HeLa S3 Mate and Plate cDNA prey library (Clontech,
Mountain View, CA). Bait and prey cells were mated by
slow shaking (40 rpm) for 24 hours at 30°C. After 20 hours,
mating cells were observed microscopically for the pres-
ence of zygotes. Mated cells were centrifuged 1,000 × g
for 10 min, and the pellet was resuspended in 5 ml 0.5X
YPDA containing 50 μg/ml kanamycin. Mated cells
(0.2 ml) were spread on each of 55 SD-LEU-TRP/X-a-Gal/
125 ng/ml AbA agar plates, and plates were incubated
30°C for 5–8 days. This concentration of AbA is consid-
ered high stringency and could exclude isolation of low-
affinity interactors. The mating efficiency was determined
by plating 1:1,000 and 1:10,000 dilutions on SD-LEU, SD-
TRP, and SD-LEU-TRP agar plates.
Blue colonies from the Y2H screen SD-LEU-TRP/X-a-
Gal/AbA plates were picked as small patches to an SD-
LEU-TRP plate, grown 2 days at 30°C, and replica plated
to agar media (SD-ADE, SD-HIS, SD-LEU-TRP/X-a-Gal,
SD-LEU-TRP/AbA) to test for activation of four reporter
genes: ADE2, HIS3, MEL1C, and AUR1-C, respectively.
Replica plates were incubated at 30°C and observed daily
for 3 days. Cells from potential positive interactors (grow-
ing on all types of reporter media and blue/light blue on
SD-LEU-TRP/X-α-Gal) were single-colony purified on
SD-LEU-TRP/X-a-Gal and incubated at 30°C for 4 days. A
single blue colony from each potential positive interaction
strain was single-colony purified a second time on SD-
LEU-TRP/X-α-Gal.
Following two rounds of streaking, the prey plasmid
from each potential positive interaction yeast strain was
isolated using the “Easy Yeast Plasmid Isolation Kit”
(Clontech, Mountain View, CA). The resulting yeast
plasmid DNAs were transformed into and subsequently
re-isolated from E. coli cells.
Testing potential positive prey plasmids for toxicity to
yeast and autoactivation of the Y2H reporter genes
Isolated prey plasmid DNAs were re-introduced into
Y2HGold cells using a yeast transformation system
(Geno Technology). Y2HGold cells containing prey plas-
mids were single-colony purified on SD-Leu agar plates
alongside a control (Y2HGold containing the empty preyvector pGADT7), and cell growth was observed after
3 days at 30C to test for toxicity. To test for false positives,
patches of Y2HGold cells containing prey plasmids were
replica plated to assess autoactivation of reporter genes on
reporter media (SD-Ade, SD-His, SD-Leu-Trp + X-α-Gal,
SD-Leu-Trp + AbA). Prey strains determined to be false
positives in yeast were excluded from the pool of identi-
fied interacting host proteins.
Bioinformatics
The 5’ and 3’ ends of human cDNA within each con-
firmed positive prey plasmid were determined by se-
quencing at the Iowa State University (ISU) DNA
Facility using primers T7-1 (AATACGACTCACTATAG)
and 3’AD (AGATGGTGCACGATGCACAG) or 3’ poly-
TA (TTTTTTTTTTTTTTTTTTTTTTTTTA), respect-
ively. The sequence data was used in a BLAST to query
the NCBI human genome and human transcript
databases.
Maintenance of protein-protein interactions at 30°C
and 37°C
Y2HGold yeast cells were separately co-transformed with
a bait plasmid (either pGBKT7 bait vector containing NP
from human influenza A strain H3N2, A/Ca/07/04 or NP
from swine influenza A strain H1N1, A/Sw/NC/44173/00)
and a prey plasmid (pGADT7 containing one of the hu-
man cDNAs isolated as a positive interactor with human
NP bait). Y2HGold cells containing known bait/prey inter-
actors pGBKT7-53 and pGADT7-T and known non-
interactors pGBKT7-Lam and pGADT7-T were used as
positive and negative controls, respectively. Additional
negative interaction controls included Y2HGold cells
containing human or swine NP (described above) and an
empty prey vector pGADT7.
All transformants were grown in YPD media in overnight
cultures and were diluted to a concentration of 5 × 106
cells/ml (OD= 0.417). 200 ml of culture was placed into a
96 well plate. A 48 sample pinner was used to spot yeast
onto 2 plates each of SD-Leu-Trp (control), and SD-His.
One plate of each type was incubated at 30°C, the other
was incubated at 37°C. Growth was assessed and images
taken 4 days after the initial plating procedure. At least two
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human NP) and prey were tested on SD-Leu-Trp and SD-
His at both 30°C and 37°C.
ß-galactosidase assay
Diploid cells containing bait and prey were prepared by
mating Y187 cells containing each of the prey plasmids
with Y2HGold cells containing each of the bait plasmids
(swine NP or human NP) on YPD agar (MatchMaker
Gold Y2H protocol, Clontech, Mountainview, CA). Eight
replicate samples of diploids were selected by subsequent
growth on SD-Leu-Trp agar for each protein interaction.
Diploid cells containing bait/prey were inoculated in 2 mL
SD-Leu/Trp liquid media and grown in a 200 rpm shaker
at 30°C overnight. 2 mL of the overnight cultures were di-
luted to 4 mL with YPD media and grown in a 200 rpm
shaker at 30°C until they reached mid-log phase (OD600 of
0.5-0.8). Cultures were separated into 1.5 mL aliquots, pel-
leted, washed once, and then resuspended in 300 μL of Z
buffer (16.1 g/L Na2HPO4⋅7H2O, 5.5 g/L NaH2PO4⋅H2O,
0.75 g/L KCl, 0.246 g/L MgSO4⋅7H2O, pH7.0). Samples of
100 μL were lysed by three freeze/thaw cycles with liquid
nitrogen and a 37°C water bath. After the cells were lysed,
the sample was split into two 150 μL aliquots. A blank
tube, containing 100uL of Z buffer, was also set up. To
analyze the enzyme activity, 350 μL of Z buffer with 0.27%
β-mercaptoethanol and 4 mg/ml of ONPG as substrate
were added. The yellow color was then allowed to develop
at 30°C, and the reaction was stopped by the addition of
200 μL of 1 M Na2CO3. To remove cell debris, the sam-
ples were centrifuged for 10 minutes at 16,000 RCF, and
OD420 values were recorded. In order to express the
enzyme activity, Miller Units were calculated using the
formula: 1000*OD420/(t*V*OD600) where t refers to the
elapsed time, and V refers to the dilution factor (0.25 in
this case).
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